WESTFORD, Mass., Feb. 6, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that President and Chief Executive Officer Michael Davin and Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at two upcoming investor conferences.
On Wednesday, February 15 at 4:00 p.m. (ET), management will give a brief presentation followed by a fireside chat at the Leerink Swann 2012 Global Healthcare Conference in New York City.
On Tuesday, February 28 at 8:30 a.m. (ET), management will present at the Citi 2012 Global Healthcare Conference in New York City.
To access the live or archived webcasts of these events, visit the "Investor Relations" portion of Cynosure's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Sharon Merrill Associates, Inc.
SOURCE Cynosure, Inc.